Causes and Clinical Significance of Bronchopulmonary Thickening

Primary Etiologies

Cigarette smoking is the leading cause of bronchial wall thickening, accounting for the majority of cases through chronic inflammatory changes and airway remodeling, according to the American Thoracic Society 1.
Organic and inorganic dusts, chemical agents, and fumes are significant causes of bronchial wall thickening, as reported by the American College of Chest Physicians 1, 2.
Severe childhood respiratory infections are associated with reduced lung function and persistent airway abnormalities in adulthood, as stated by the American Thoracic Society 1.
Asthma and airway hyperresponsiveness are independent predictors of chronic airflow limitation and can lead to airway remodeling with wall thickening, according to the American Thoracic Society 1.
Chronic rhinosinusitis is associated with a higher prevalence of bronchial wall thickening, as reported by the American College of Radiology 3, 4.

Chronic inflammation in the respiratory tract leads to increased mucus production, purulence, and eventual pathological changes in airway walls, as described by the American College of Chest Physicians 2.
The presence of inflammatory cells within the airway wall and lumen drives the remodeling process, according to the British Thoracic Society 6, 7.
Changes in mucus gland thickness relate to sputum production but not necessarily to loss of respiratory function, as reported by the British Thoracic Society 6, 7.

Bronchial wall thickening is the most common CT abnormality in chronic cough patients, present in 57-62% of cases, as reported by the American College of Radiology 3, 4.
Wall thickening can be quantitatively measured and shows significant association with cough symptoms in COPD patients, according to the American College of Radiology 3, 4.
Air trapping indicates functional small airway obstruction even when airways appear structurally normal, as reported by the American College of Radiology 3, 4.

Not all bronchial wall thickening is clinically significant, and screening studies show up to 20% of elderly patients have CT abnormalities including wall thickening without respiratory symptoms, as stated by the American College of Radiology 3, 4.
HRCT should be reserved for patients failing empiric treatment, symptoms persisting beyond 8 weeks, or indeterminate chest radiograph findings rather than routine screening, according to the American College of Radiology 3, 4.